Univ. Bordeaux, ISPED, Centre Inserm U897 - Epidemiologie-Biostatistique, F-33000 Bordeaux, France.
Vaccine. 2013 Mar 1;31(11):1516-22. doi: 10.1016/j.vaccine.2013.01.007. Epub 2013 Jan 11.
Due to the high burden of pneumonia in Indonesia, the inclusion of pneumococcal conjugate vaccine (PCV) into Indonesia's National Immunization Program (NIP) is recommended by World Health Organization. Prior to the introduction of new vaccines, it is imperative to assess the perceptions of the public and medical community about the disease and the vaccine. The purpose of this qualitative study was to explore the knowledge, perceptions, and attitudes of mothers and health care providers (HCPs) toward PCV in Bandung, West Java, Indonesia.
Fifty-five respondents (26 mothers and 29 HCPs) were interviewed at public and private health care facilities in Bandung using semi-structured interviews in May-June 2011. Data were analyzed manually according to pre-defined themes.
Although most mothers had low knowledge about PCV, did not perceive themselves as susceptible to the disease, perceived that cost was the main barrier to PCV access, and obtained little information on PCV, they considered pneumonia as a severe disease and a priority health problem, perceived benefits of the vaccine, and were likely to adopt it. Similarly, knowledge about PCV among most HCPs was limited. Despite perceiving cost as the main barrier, most HCPs perceived benefits of the vaccine, susceptibility and severity of the disease, regarded pneumonia as a priority health problem, and were likely to suggest the new vaccination.
DISCUSSION/CONCLUSIONS: Despite the poor knowledge of mothers and HCPs about PCV, they are aware of the high burden of pneumonia and the need for a vaccine in the NIP. Perceived severity and benefits among mothers, and, additionally, perceived susceptibility among HCPs were manifested in the willingness to accept PCV. The findings would contribute to better understanding the factors, which could support decision-making about vaccine introduction, and be utilized for developing suitable messages for mothers and HCPs.
由于印度尼西亚肺炎负担沉重，世界卫生组织建议将肺炎球菌结合疫苗（PCV）纳入印度尼西亚国家免疫规划（NIP）。在引入新疫苗之前，必须评估公众和医疗社区对该疾病和疫苗的看法。本定性研究的目的是探讨印度尼西亚万隆的母亲和医疗保健提供者（HCP）对 PCV 的知识、看法和态度。
2011 年 5 月至 6 月，在万隆的公共和私人医疗保健设施中，使用半结构式访谈对 55 名受访者（26 名母亲和 29 名 HCP）进行了访谈。根据预先确定的主题，手动分析数据。
尽管大多数母亲对 PCV 的了解程度较低，认为自己不易感染该疾病，认为费用是获得 PCV 的主要障碍，并且很少获得有关 PCV 的信息，但她们认为肺炎是一种严重的疾病，是一个优先的健康问题，认为疫苗有好处，并且可能会采用它。同样，大多数 HCP 对 PCV 的了解也有限。尽管大多数 HCP 认为费用是主要障碍，但他们认为疫苗有好处，疾病的易感性和严重性，认为肺炎是一个优先的健康问题，并且可能会建议接种新疫苗。
讨论/结论：尽管母亲和 HCP 对 PCV 的了解程度较差，但他们意识到肺炎负担沉重，NIP 需要疫苗。母亲表现出对疾病严重性和疫苗好处的认识，而 HCP 则表现出对疾病易感性的认识，这体现在他们愿意接受 PCV。研究结果有助于更好地了解支持疫苗引入决策的因素，并为母亲和 HCP 开发合适的信息。
